Do U.S. private label buyers need MoCRA product listing for eye cream and eye patches?

In the U.S., MoCRA facility registration and cosmetic product listing are typically handled by the brand's U.S. Responsible Person, not the factory alone. We can support you with the product and manufacturing documentation needed to complete listing, but we cannot provide legal advice.

US buyer view Launch planning Updated: January 27, 2026
Chat on WhatsApp
Best for
US brand owners, Amazon/FBA sellers, distributors, and private label buyers
Core intent
Who submits, what data is needed, and how to plan timelines before production

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

  • For eye cream and eye patches sold in the U.S. as cosmetics, MoCRA may require FDA facility registration and cosmetic product listing, depending on the roles in the supply chain.
  • In most private label cases, the brand owner/Amazon seller (as the U.S.
  • Responsible Person) files the product listing, while the manufacturer provides supporting details.
  • If you plan drug-like claims (e.g., treating medical conditions), requirements can change, so please confirm your claim direction.
  • From our side, we can help prepare the practical package: formula/INCI and shade/variant info, product concept and labeling copy support, and testing/document tracking (we can arrange product inspection and follow the report).
  • We can also provide standard manufacturing credentials and documentation support.
  • Execution-wise, our typical MOQ is 1,000-3,000 units (simple items like masks can start at 1,000; more complex sets often 3,000).
  • Bulk production is usually 10-20 working days after final sample approval.
  • Packaging ordering often takes 10-30 working days (e.g., glass bottle ~15 days, acrylic bottle ~30 days; single box ~15 days).
  • Do you already have a designated U.S.
  • Responsible Person and final claim set?
Buyer outcome
A launch-ready compliance plan: inputs collected, roles assigned, and update cadence defined.
Most common blocker
Missing facility information + inconsistent ingredient/label snapshots across SKUs.
⚠️
This page is a practical buyer guide. For definitive requirements and updates, use FDA resources and qualified regulatory counsel.
  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).